pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
about
Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon CalcitoninInvestigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitoninLessons learned from the clinical development of oral peptides.pH-Responsive nanoparticles for drug delivery.The potential of chitosan for the oral administration of peptides.Influence of food intake on the bioavailability and efficacy of oral calcitonin.A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization.Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective.Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.Oral salmon calcitonin--pharmacology in osteoporosis.Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly(methyl vinyl ether maleic acid) bioadhesive nanoparticles.Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants.The effect of inorganic salt type and concentration on hydrophilic drug loading into microspheres using the emulsion/solvent diffusion method.Preparation of nanocapsules containing the two-phase core materials.Mechanisms of burst release from pH-responsive polymeric microparticles.
P2860
Q33368276-C0F62C85-0221-4346-9C6F-90DA2459AAD1Q33389566-A72A1F50-0731-47CC-9F47-C33C6861F188Q35557405-8601565C-4994-4C44-9CE8-5C6DC5BDC1BFQ36047019-D595E076-2F7F-45ED-A86A-4325B455AA96Q36316822-4C85D01A-2428-429F-BB5C-769DA2BA2D5BQ37184422-52701C0F-A808-4F89-8954-88DB5341B91AQ37527859-86542FAB-F35A-4F6E-911B-A821A9C49F6AQ37565676-844C2F5E-3FC1-4AF9-9831-ABD0CC8DC2ADQ37775799-218236AD-AE5B-40F7-8FC2-E63EDB3F5C6EQ37798836-B41D7019-5DF4-4338-BCB3-682B05499EDAQ38256081-DA315875-BC0F-40C4-A08F-6ECF3835D637Q42940972-4EE8227E-3337-4B66-B9C6-1169D0648C93Q46230879-E0E60288-B1A8-4929-B987-5BBBA23131CFQ46958502-1A197D28-5922-4330-9824-3BDE8364DCCAQ50514708-BBE0342B-A853-4640-B16C-19DA0C5CC59C
P2860
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@en
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@nl
type
label
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@en
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@nl
prefLabel
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@en
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@nl
P2093
P1476
pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
@en
P2093
Alf Lamprecht
Hirofumi Takeuchi
Hiromitsu Yamamoto
Yoshiaki Kawashima
P356
10.1016/J.JCONREL.2004.02.001
P407
P577
2004-07-01T00:00:00Z